P. Russo

P. Russo, A. Hakimi, P. Kim, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.

A. Lenis, M. Ladanyi, K. Offit, 2021, European urology oncology.

Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors.

P. Russo, A. Hakimi, D. Sjoberg, 2015, Urology.

Outcome of the Prenatally Diagnosed Congenital Cystic Adenomatoid Lung Malformation: A Canadian Experience

P. Russo, D. Filiatrault, D. Pugash, 2001, Fetal Diagnosis and Therapy.

Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.

W. Lowrance, T. Jang, R. Motzer, 2013, The Journal of urology.

renal cell carcinoma: Role of MR Imaging in the Assessment of Muscular Venous Branch Invasion 1

H. Hricak, P. Russo, O. Akin, 2013 .

Renal vein or inferior vena caval extension in patients with renal cortical tumors: impact of tumor histology.

R. Simmons, P. Russo, V. Reuter, 2004, The Journal of urology.

Pathologic findings at the time of nephrectomy for renal mass

P. Russo, C. Morash, S. Campbell, 1997, Annals of Surgical Oncology.

Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.

M. Kattan, P. Russo, V. Reuter, 2003, Urologic oncology.

COMPARATIVE GENOMIC PROFILING OF MATCHED PRIMARY AND METASTATIC TUMORS IN RENAL CELL CARCINOMA: MP39‐02

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.

The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan‐kettering cancer center experience

P. Russo, W. Fair, W. Whitmore, 1994, Cancer.

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

Andrew J Vickers, Paul Russo, William C Huang, 2006, The Lancet. Oncology.

A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy

P. Russo, J. Coleman, A. Tin, 2021, International braz j urol : official journal of the Brazilian Society of Urology.

Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity.

P. Russo, J. Coleman, A. Vickers, 2020, European urology oncology.

Editorial Comment.

P. Russo, 2019, Urology.

Routine drain placement after partial nephrectomy is not always necessary.

P. Russo, M. Bernstein, G. Godoy, 2011, The Journal of urology.

Deleterious renal functional outcomes after radical nephrectomy.

P. Russo, 2011, European urology.

Complications after radical and partial nephrectomy as a function of age.

W. Lowrance, David S. Yee, P. Russo, 2010, The Journal of urology.

Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

P. Russo, 2010, European urology.

Editorial comment. A new diagnosis of a small kidney tumor.

P. Russo, 2009, Urology.

Predictors and oncological outcomes following positive surgical margins at partial nephrectomy

P. Russo, R. Thompson, B. Leibovich, 2009 .

Editorial comment on: preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance.

P. Russo, 2008, European urology.

Editorial comment on: Robotic partial nephrectomy for complex renal tumors: surgical technique.

P. Russo, 2008, European urology.

Comparison of laparoscopic radical and partial nephrectomy: Effects on long-term serum creatinine

P. Russo, 2008 .

Open partial nephrectomy: an essential contemporary operation

P. Russo, 2006, Nature Clinical Practice Urology.

The Type of Urinary Diversion After Radical Cystectomy Significantly Impacts on the Patient’s Quality of Life

P. Russo, G. Grimaldi, M. McGuire, 2000, Annals of Surgical Oncology.

Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations

P. Russo, A. Bex, N. Graafland, 2022, European urology open science.

Systemic Immunological Determinants of Oncological Outcomes After Surgery for Localized Renal Cell Carcinoma.

P. Russo, J. Coleman, A. Vickers, 2022, Clinical genitourinary cancer.

Perioperative clinical thromboembolic events after radical or partial nephrectomy.

P. Russo, A. Vickers, A. Shabsigh, 2006, Urology.

Surgical management of renal tumors 4 cm. or less in a contemporary cohort.

P. Russo, V. Reuter, J. Katz, 2000, The Journal of urology.

The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination.

M. Bilsky, P. Russo, I. Ostrovnaya, 2020, Urologic oncology.

Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan‐Kettering experience

P. Russo, J. Saranchuk, A. Touijer, 2004, BJU international.

A comparison of hospital-based charges following partial and radical nephrectomy.

P. Russo, J. Katz, J. McKiernan, 2002, Urologic oncology.

The association between statin medication and progression after surgery for localized renal cell carcinoma.

P. Russo, V. Reuter, A. Hakimi, 2012, The Journal of urology.

Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy.

J. Eastham, F. Montorsi, P. Russo, 2019, European urology.

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

P. Russo, J. Coleman, E. Zabor, 2018, World Journal of Urology.

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma

R. Motzer, P. Russo, C. Sternberg, 2018, Clinical Cancer Research.

Impact of unnecessary exploratory laparotomy on the treatment of patients with metastatic germ cell tumor.

P. Russo, J. Sheinfeld, A. Stephenson, 2004, The Journal of urology.

MP50-18 OBSTRUCTIVE SLEEP APNEA AND HIGH FUHRMAN GRADE IN PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA TREATED WITH NEPHRECTOMY

P. Russo, R. Farré, N. Fossati, 2015 .

A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder

P. Russo, M. Milowsky, B. Bochner, 2008, Cancer.

Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery.

P. Russo, W. Fair, W. Whitmore, 1990, The Journal of urology.

Phase II trial of ZD1839 (IRESSA™) in patients with advanced renal cell carcinoma

R. Motzer, J. Bacik, P. Russo, 2003, Investigational New Drugs.

Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.

P. Russo, D. Bajorin, W. Fair, 1996, The Journal of urology.

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma

P. Russo, 2009 .

Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin

P. Russo, C. Przybycin, John E. Musser, 2010, Nature Reviews Urology.

Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma

R. Motzer, P. Russo, A. Hakimi, 2021, Cancer.

The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors

E. Dmitrovsky, N. Geller, P. Russo, 1990, Cancer.

High‐dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

P. Russo, R. Motzer, W. Fair, 1992, Cancer.

Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.

P. Russo, V. Reuter, A. Hakimi, 2019, Clinical genitourinary cancer.

Chromophobe renal cell carcinoma: results from a large single-institutional series

P. Russo, V. Reuter, I. Ostrovnaya, 2019 .

Adult Spermatic Cord Sarcomas: Management and Results

P. Russo, J. Coleman, M. Brennan, 2003, Annals of Surgical Oncology.

Importance of wide re‐resection in adult spermatic cord sarcomas: Report on oncologic outcomes at a single institution

P. Russo, J. Coleman, D. Sjoberg, 2018, Journal of surgical oncology.

Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.

P. Russo, W. Fair, W. Whitmore, 1987, Cancer research.

TRPM‐2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK‐906 (finasteride), and coumarin

P. Russo, G. Perez, W. Heston, 1994, The Prostate.

A case of high-risk penile epithelioid hemangioendothelioma

P. Russo, A. Wedmid, R. Maki, 2009, Nature Reviews Urology.

Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literature

A. Hauschild, P. Russo, T. Kreusch, 2008, Melanoma research.

Intracardiac teratoma 15 years after treatment of a nonseminomatous germ cell tumor.

P. Russo, V. Reuter, G. Bosl, 1993, The Journal of urology.

Long-term response with sunitinib for metastatic renal cell carcinoma.

R. Motzer, P. Russo, G. V. Kondagunta, 2006, Urology.

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.

R. Motzer, J. Bacik, P. Russo, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A qualitative framework of non-selection factors for cytoreductive nephrectomy

P. Russo, R. Motzer, M. Voss, 2021, World Journal of Urology.

Progression from tubulovillous adenoma to high-grade adenocarcinoma in Indiana pouch urinary diversion

P. Russo, Katie S. Murray, Nick W. Liu, 2017, Urology case reports.

Tubulovillous adenoma in an Indiana pouch urinary diversion managed by endoscopic resection

P. Russo, A. Gopalan, Jay D. Raman, 2007, International journal of urology : official journal of the Japanese Urological Association.

To clamp or not to clamp the main renal artery: the debate continues.

P. Russo, I. Derweesh, 2014, European urology.

Magnetic resonance imaging compared with echocardiography in the evaluation of pulmonary artery abnormalities in children with tetralogy of Fallot following palliative and corrective surgery

P. Russo, K. Crisci, B. Robinson, 1997, Pediatric Radiology.

Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.

P. Russo, A. Hakimi, J. Coleman, 2019, European urology focus.

Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.

P. Russo, J. Wren, J. Coleman, 2018, European urology.

Urine Neutrophil Gelatinase-Associated Lipocalin (uNGAL) as a Marker for Acute Kidney Injury in Kidney Surgery Patients

P. Russo, J. Wren, M. Fleisher, 2014 .

Neutrophil gelatinase‐associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two‐kidney porcine model

P. Russo, D. Sjoberg, M. Fleisher, 2013, BJU international.

Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery.

P. Russo, J. Wren, M. Fleisher, 2013, The Journal of urology.

Effects of Intermittent Diet hvIstÃ 1⁄4 bestrol Diphosphate Administration on the R 3327 Rat Prostatic Carcinoma

P. Russo, W. Fair, W. Whitmore, 2006 .

Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient.

P. Russo, S. Fine, Sounak Gupta, 2019, Urology.

Potential new strategies for the treatment of renal medullary carcinoma

P. Russo, 2017, BJU international.

Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)

P. Russo, R. Motzer, T. Garg, 2012, BJU international.

Renal oncocytosis: imaging considerations

P. Russo, S. Tickoo, C. Riedl, 2009, Abdominal Imaging.

Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management.

P. Russo, A. Hakimi, J. Coleman, 2021, Urology.

EDITORIAL COMMENT.

P. Russo, 2022, Urology.

Hematuria 5 Months after Left Radical Nephrectomy

P. Russo, W. Fair, B. McClennan, 1983 .

Adult prostatic sarcoma

P. Russo, V. Reuter, B. Demas, 2004, Abdominal Imaging.

Leydig cell tumor after treatment for Ewing's sarcoma

P. Russo, A. Huvos, J. Healey, 2007, Pediatric blood & cancer.

Expression of neuropeptides in normal and abnormal appendices.

P. Russo, S. Bouchard, N. Adzick, 2001, Journal of pediatric surgery.

Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.

R. Motzer, P. Russo, A. Hakimi, 2019, Clinical genitourinary cancer.

Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.

P. Russo, D. Sjoberg, E. Vertosick, 2016, Urologic oncology.

Myocutaneous flaps in genitourinary oncology.

P. Russo, D. Hidalgo, T. Chaglassian, 1994, The Journal of urology.

Renal cryoablation: a new treatment in need of careful clinical investigation

P. Russo, 2006, Nature Clinical Practice Oncology.

Feasibility and outcomes of repeat partial nephrectomy

P. Russo, 2009 .

Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape

P. Russo, V. Reuter, R. Motzer, 2022, Genome medicine.

Pediatric renal cell carcinoma: Single institution 25 year case series and initial experience with partial nephrectomy

P. Russo, 2006 .

Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation.

P. Russo, W. Fair, P. Brenner, 1995, British journal of urology.

Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.

J. Cheville, P. Russo, V. Reuter, 2008, Cancer research.

Metastatic melanoma of the tongue arising from oral melanosis.

A. Hauschild, F. Egberts, P. Russo, 2008, Archives of dermatology.

A case of Castleman's disease that presented as a retroperitoneal mass

P. Russo, A. Gopalan, A. Dash, 2007, Nature Clinical Practice Urology.

Renal oncocytosis: management and clinical outcomes.

W. Lowrance, David S. Yee, P. Russo, 2011, The Journal of urology.

Systemic therapy for renal cell carcinoma.

R. Motzer, P. Russo, 2000, The Journal of urology.

Prognostic significance of erythropoietin expression in human renal cell carcinoma

P. Russo, 2008 .

Long‐Term Efficacy of Subcutaneous Sweat Gland Suction Curettage for Axillary Hyperhidrosis: A Prospective Gravimetrically Controlled Study

A. Hauschild, S. Lischner, P. Russo, 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Developments in the surgical management of sporadic synchronous bilateral renal tumours

W. Lowrance, David S. Yee, P. Russo, 2010, BJU international.

Bilateral non-familial renal cell carcinoma

P. Russo, V. Reuter, G. Grimaldi, 1998, Annals of Surgical Oncology.

Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate.

P. Russo, W. Fair, M. Packer, 1984, The Journal of urology.

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

P. Russo, M. Mazumdar, D. Bajorin, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High energy shock waves suppress tumor growth in vitro and in vivo.

R A Stephenson, M. Melamed, P. Russo, 1986, The Journal of urology.

Open Mini-Flank Partial Nephrectomy: An Essential Contemporary Operation

P. Russo, R. Mano, 2014, Korean journal of urology.

Oncological and renal medical importance of kidney-sparing surgery

P. Russo, 2013, Nature Reviews Urology.

Oncological outcomes of partial nephrectomy for renal carcinoma greater than 4 cm

P. Russo, 2011, Current opinion in urology.

Partial nephrectomy for renal cancer: Part I

P. Russo, 2010, BJU international.

Port site metastasis after surgery for renal cell carcinoma: harbinger of future metastasis.

P. Russo, S. Bhayani, M. Iwamura, 2014, The Journal of urology.

Adult urological sarcoma.

P. Russo, W. Fair, M. Brennan, 1992, The Journal of urology.

Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome–associated Renal Cancer: Recognition of the Syndrome by Pathologic Features and the Utility of Detecting Aberrant Succination by Immunohistochemistry

M. Berger, P. Russo, V. Reuter, 2014, The American journal of surgical pathology.

Non-squamous cell carcinoma of the penis: single-center, 15-year experience

P. Russo, G. Dalbagni, J. Sfakianos, 2014, World Journal of Urology.

Influence of smoking status on the disease‐related outcomes of patients with tobacco‐associated superficial transitional cell carcinoma of the bladder

P. Russo, N. Fleshner, H. Herr, 1999, Cancer.

Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes.

P. Russo, C. Morash, D. Theodorescu, 1996, Journal of Urology.

The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications.

L. Kavoussi, J. Patard, F. Montorsi, 2010, European urology.

Urologic emergencies in the cancer patient.

P. Russo, 2000, Seminars in oncology.

Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line.

P. Russo, W. Heston, D. Covey, 1987, Cancer research.

The in vitro effect of high energy shock waves on human prostate cancer cell line PC-3

P. Russo, W. Fair, R. Stephenson, 1985 .

Mucinous adenocarcinoma of the prostate: a case report of long-term disease-free survival and a review of the literature.

P. Russo, S. Olgac, A. Rhee, 2004, Urology.

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.

P. Russo, M. Galsky, B. Bochner, 2007, Urology.

Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy

C. Sander, N. Socci, N. Schultz, 2014, Clinical Cancer Research.

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma

N. Schultz, R. Motzer, P. Russo, 2021, Clinical Cancer Research.

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.

C. Leslie, P. Russo, V. Reuter, 2021, Cancer cell.

Long-term mortality in patients with germ cell tumors: effect of primary cancer site on cause of death.

P. Russo, D. Feldman, B. Konety, 2014, Urologic oncology.

Suppression of in vitro and in vivo tumor growth by high- energy shock waves

P. Russo, W. Fair, W. Heston, 1985 .

Salvage chemotherapy for patients with germ cell tumors. The memorial sloan‐kettering cancer center experience (1979–1989)

N. Geller, R. Motzer, P. Russo, 1991, Cancer.

Wilms tumor and multicystic dysplastic kidney disease.

P. Russo, P. Russo, Y. Homsy, 1997, The Journal of urology.

Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel–Lindau gene and hypoxia-inducible factor pathway-related proteins

M. Rosenblum, P. Russo, V. Reuter, 2011, Modern Pathology.

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Ludmila V. Danilova, C. Sander, E. V. Van Allen, 2017, Genome Biology.

Epidemiology of Renal Cell Carcinoma.

F. Bray, K. Bensalah, U. Capitanio, 2019, European urology.

Evaluation of renal masses with contrast-enhanced ultrasound: initial experience.

P. Russo, S. Tickoo, M. Gonen, 2011, AJR. American journal of roentgenology.

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

David R. Jones, N. Schultz, M. Ladanyi, 2021, Cell.

Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets

N. Schultz, M. Berger, William Lee, 2016, Nature Communications.

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival

E. Wallen, U. Capitanio, F. Montorsi, 2016, Journal of surgical oncology.

Mode of presentation of renal cell carcinoma provides prognostic information.

Paul Russo, P. Russo, Cheryl T. Lee, 2002, Urologic oncology.

Renal mass within a horseshoe kidney: preoperative evaluation with three-dimensional helical computed tomography.

P. Russo, S. Hilton, P Russo, 2001, Urology.

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

E. Wallen, F. Montorsi, P. Russo, 2014, Current Urology Reports.

Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial.

Steven P. Larson, P. Russo, R. Uzzo, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.

C. Sander, P. Laird, N. Schultz, 2013, Journal of the National Cancer Institute.

Ureteral decompression in advanced nonurologic malignancies

P. Russo, S. Donat, 1996, Annals of Surgical Oncology.

Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically

P. Russo, A. Hakimi, R. Farré, 2016, World Journal of Urology.

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma

Scott R. Kennedy, C. Sander, N. Schultz, 2019, eLife.

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

David S. Tourigny, P. Russo, J. Coleman, 2022, bioRxiv.

The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma.

P. Russo, A. Hakimi, D. Sjoberg, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.

J. Cheville, V. Seshan, E. Papaemmanuil, 2017, JCI insight.

Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.

P. Russo, R. Motzer, S. Eggener, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance.

P. Russo, F. Rabbani, H. Herr, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adult genitourinary sarcoma: the 25-year Memorial Sloan-Kettering experience.

C. Antonescu, P. Russo, M. Brennan, 2006, The Journal of urology.

Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.

H. Moch, P. Russo, P. Ratcliffe, 2016, European urology.

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma

K. Offit, P. Russo, J. Coleman, 2017, Cancer.

Sarcomatoid renal cell carcinoma: biology, natural history and management

R. Motzer, P. Russo, A. Hakimi, 2020, Nature Reviews Urology.

Renal cell carcinoma: Associations between tumor imaging features and epidemiological risk factors

H. Hricak, P. Russo, O. Akin, 2020, European journal of radiology.

Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers

T. Ho, P. Russo, A. Hakimi, 2020, Scientific Reports.

Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.

R. Motzer, P. Russo, I. Ostrovnaya, 2019, The Lancet. Oncology.

Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.

R. Motzer, P. Russo, V. Reuter, 2019, European urology focus.

Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes.

R. Motzer, P. Russo, A. Hakimi, 2019, Clinical genitourinary cancer.

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

R. Motzer, P. Russo, J. Hsieh, 2017, Urologic oncology.

Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.

M. Kattan, P. Russo, Changhong Yu, 2016, European urology focus.

Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.

R. Motzer, P. Russo, V. Reuter, 2017, European urology focus.

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

R. Motzer, P. Russo, A. Hakimi, 2017, Urologic oncology.

Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection

Chris Sander, Paul Russo, Yiyu Dong, 2017, Nature Communications.

Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

R. Motzer, P. Russo, A. Hakimi, 2016, European urology focus.

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

H. Kume, Y. Homma, R. Motzer, 2016, European urology focus.

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

A. Jacobsen, K. Offit, R. Klein, 2016, Cancer.

TCEB1-mutated Renal Cell Carcinoma: A Distinct Genomic and Morphologic Subtype

C. Sander, H. Kume, Y. Homma, 2014, Modern Pathology.

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

R. Motzer, P. Russo, A. Hakimi, 2014, Cancer medicine.

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

G. Ciriello, R. Motzer, P. Russo, 2014, The Journal of urology.

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

R. Motzer, P. Russo, T. Choueiri, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Resection of metastatic renal cell carcinoma.

M. Burt, P. Russo, C. Pavlovich, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.

P. Russo, V. Reuter, R. Motzer, 2007, Journal of Urology.

Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression

R. Motzer, P. Russo, V. Reuter, 2020, Clinical Cancer Research.

Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with locally advanced renal cell carcinoma (RCC) (PROTECT).

R. Motzer, P. Russo, R. Motzer, 2017 .

The contemporary role of lymph node dissection in the management of renal cell carcinoma

P. Russo, J. Pinthus, P. Zaręba, 2018, Therapeutic advances in urology.

Lymph node dissection in renal cell carcinoma.

J. Patard, U. Capitanio, P. Russo, 2011, European urology.

Partial nephrectomy: The rationale for expanding the indications

R. Simmons, P. Russo, R. Motzer, 2002, Annals of Surgical Oncology.

Renal cell carcinoma : clinical features and management.

P. Russo, 2001, Methods in molecular medicine.

Sunitinib therapy in renal cell carcinoma

P. Russo, R. Motzer, M. O'Brien, 2008, BJU international.

Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma: An Immunohistochemical Study Comparing 2 Antibodies

L. Qin, R. Motzer, P. Russo, 2008, The American journal of surgical pathology.

Renal Cell Carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumors

M. Kattan, H. Hricak, P. Russo, 2016 .

Metanephric adenoma of the kidney: clinical and radiological study of nine cases

P. Russo, C. Bastide, J. Rambeaud, 2009, BJU international.

Significance of Peritumoral Vascularity on CT in Evaluation of Renal Cortical Tumor

H. Hricak, P. Russo, C. Moskowitz, 2007, Journal of computer assisted tomography.

Solid renal cortical tumors: differentiation with CT.

Chaya S Moskowitz, Paul Russo, Hedvig Hricak, 2007, Radiology.

Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.

M. Kattan, P. Russo, V. Reuter, 2006, The Journal of urology.

The impact of tumour location on the histological subtype of renal cortical tumours

M. Kattan, P. Russo, A. Bach, 2006, BJU international.

Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm

P. Russo, A. Vickers, A. Dash, 2006, BJU international.

Mini‐flank supra‐11th rib incision for open partial or radical nephrectomy

P. Russo, C. Diblasio, M. Snyder, 2006, BJU international.

A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.

M. Kattan, P. Russo, V. Reuter, 2005, The Journal of urology.

Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.

M. Kattan, P. Russo, C. Diblasio, 2004, The Journal of urology.

Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.

M. Kattan, L. Richstone, P. Russo, 2004, The Journal of urology.

Long-term follow-up of bilateral sporadic renal tumors.

M. Kattan, R. Simmons, P. Russo, 2003, Urology.

Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.

M. Kattan, R. Simmons, P. Russo, 2002, Urology.

Natural history of chronic renal insufficiency after partial and radical nephrectomy.

Paul Russo, R. Simmons, P. Russo, 2002, Urology.

Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.

F. Waldman, P. Russo, V. Reuter, 2002, Journal of Urology.

Localized renal cell carcinoma

P. Russo, 2001, Current treatment options in oncology.

Second primary malignancies associated with renal cell carcinoma: influence of histologic type.

P. Russo, V. Reuter, J. Katz, 2000, Urology.

Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer

R. Motzer, P. Russo, A. Vickers, 2007, TheScientificWorldJournal.

Appendicitis in children and young adults: Doppler sonographic-pathologic correlation.

P. Russo, M. Lafortune, D. Filiatrault, 1996, AJR. American journal of roentgenology.

Diagnostic and therapeutic procedures for management of melanoma during pregnancy: risks for the fetus?

A. Hauschild, F. Egberts, S. Lischner, 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.

Coral L. Atoria, W. Lowrance, E. Elkin, 2015, JAMA surgery.

PROGNOSTIC IMPACT OF HISTOLOGICAL SUBTYPE IN PATIENTS WITH SURGICALLY TREATED LOCALIZED RENAL CELL CARCINOMA

Caroline, P. Russo, V. Reuter, 2014 .

Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.

Paul Russo, Victor E Reuter, P. Russo, 2009, The Journal of urology.

Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma

M. Kattan, R. Motzer, P. Russo, 2006, Annals of Surgical Oncology.

Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer

P. Russo, G. Dalbagni, K. Conlon, 1998, Annals of Surgical Oncology.

Role of Immunohistochemistry in the Evaluation of Needle Core Biopsies in Adult Renal Cortical Tumors: An Ex Vivo Study

P. Russo, V. Reuter, S. Tickoo, 2011, The American journal of surgical pathology.

Complications of radical and partial nephrectomy in a large contemporary cohort.

P. Russo, A. Hakimi, A. Stephenson, 2004, The Journal of urology.

Open partial nephrectomy. Personal technique and current outcomes.

P. Russo, 2011, Archivos espanoles de urologia.

An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy.

P. Russo, O. Akin, C. Karlo, 2016, European urology.

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Paul Russo, William C Huang, E. Elkin, 2009, The Journal of urology.

Assessing the impact of ischaemia time during partial nephrectomy.

Michael Stöckle, Francesco Montorsi, Paul Russo, 2009, European urology.

Salvage radical prostatectomy after radiation therapy and brachytherapy.

P. Russo, 2000, Journal of endourology.

Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.

Paul Russo, Jonathan Coleman, P. Russo, 2012, The Journal of urology.

Cystectomy for bladder cancer: a contemporary series.

P. Russo, V. Reuter, G. Dalbagni, 2001, The Journal of urology.

Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function.

P. Russo, A. Vickers, W. Huang, 2006, The Journal of urology.

Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series.

P. Russo, A. Hakimi, A. Sankin, 2016, Urology.

The association of renal cell carcinoma with gastrointestinal stromal tumors

P. Russo, A. Hakimi, J. Coleman, 2018, Journal of surgical oncology.

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma.

L. Schwartz, R. Motzer, J. Bacik, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interferon-Alfa a s a C omparative T reatment f or C linical Trials o f N ew T herapies A gainst A dvanced R enal Cell C arcinoma

R. Motzer, J. Bacik, P. Russo, 2002 .

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma

R. Motzer, P. Russo, A. Hakimi, 2021, Clinical Cancer Research.

Congenital adenomatoid malformation of the lung: current management and prognosis.

P. Russo, D. Filiatrault, J. Laberge, 1991, Journal of pediatric surgery.

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

P. Russo, 2006 .

Surgical resection of brain metastases from renal cell carcinoma in 50 patients.

P. Russo, J. Galicich, E. Arbit, 1996, Urology.

Open partial nephrectomy: an essential operation with an expanding role

P. Russo, 2007, Current opinion in urology.

Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours

Paul Russo, P. Russo, B. Carver, 2007, BJU international.

Phase II trial of thalidomide for patients with advanced renal cell carcinoma.

R. Motzer, J. Bacik, P. Russo, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolated congenital esophageal stenosis.

P. Russo, S. Yazbeck, S. Murphy, 1995, Journal of pediatric surgery.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

C. Brennan, M. Ladanyi, M. Berger, 2019, Nature Genetics.

The role of surgery in the treatment of clinically isolated adrenal metastasis

M. Burt, P. Russo, D. Coit, 1998, Cancer.

Chromophobe Renal Cell Carcinoma: A Clinicopathologic Study of 203 Tumors in 200 Patients With Primary Resection at a Single Institution

P. Russo, V. Reuter, S. Tickoo, 2011, The American journal of surgical pathology.

Analysis of lymph node dissection in patients with ≥7-cm renal tumors

P. Russo, M. Kent, M. Bernstein, 2014, World Journal of Urology.

Survival rates after resection for localized kidney cancer: 1989 to 2004

T. Jang, P. Russo, W. Huang, 2008, Cancer.

Lymph node dissection during cytoreductive nephrectomy: A retrospective analysis

P. Russo, M. Kent, M. Bernstein, 2014, International journal of urology : official journal of the Japanese Urological Association.

Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.

F. Montorsi, P. Russo, W. Huang, 2011, European urology.

Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

W. Lowrance, P. Russo, V. Reuter, 2011, Journal of Urology.

Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

U. Capitanio, F. Montorsi, P. Russo, 2018, Urologic oncology.

Role of Surgery in Locally Recurrent and Metastatic Renal Cancer

P. Russo, 2013 .

Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival

R. Motzer, P. Russo, M. Snyder, 2006, BJU international.

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

E. V. Van Allen, N. Weinhold, William Lee, 2016, Genome Biology.

Multi-modal treatment for metastatic renal cancer: the role of surgery

P. Russo, 2010, World Journal of Urology.

Predicting the histology of renal masses using preoperative Doppler ultrasonography.

P. Russo, G. Raj, A. Iasonos, 2007, The Journal of urology.

Use of DWI in the Differentiation of Renal Cortical Tumors.

H. Hricak, P. Russo, O. Akin, 2016, AJR. American journal of roentgenology.

Treatment outcome for metastatic papillary renal cell carcinoma patients

R. Motzer, J. Bacik, P. Russo, 2006, Cancer.

Renal cell carcinoma: presentation, staging, and surgical treatment.

P. Russo, P Russo, 2000, Seminars in oncology.

Malignant small-cell tumor of the thoracopulmonary region: 'Askin tumor'.

P. Russo, J. Laberge, C. Moir, 1989, Journal of pediatric surgery.

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

J. Humm, S. Larson, M. Gönen, 2007, The Lancet. Oncology.

Urinary Diversion After Total Pelvic Exenteration for Rectal Cancer

P. Russo, J. Guillem, P. Paty, 1999, Annals of Surgical Oncology.

An evaluation of the role of tumor load in cytoreductive nephrectomy.

R. Motzer, P. Russo, O. Akin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Complete metastasectomy for renal cell carcinoma: Comparison of five solid organ sites

P. Russo, D. Sjoberg, E. Vertosick, 2016, Journal of surgical oncology.

Cytoreductive Nephrectomy - Patient Selection Is Key.

P. Russo, R. Motzer, 2018, The New England journal of medicine.

Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.

P. Russo, M. O'Brien, 2008, The Urologic clinics of North America.

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma.

R. Motzer, J. Bacik, P. Russo, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline.

A. Evans, W. Lowrance, Nofisat Ismaila, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

N. Schultz, P. Russo, V. Reuter, 2021, bioRxiv.

Renal cell carcinoma: A nomogram for the CT imaging-inclusive prediction of indolent, non-clear cell renal cortical tumours.

M. Kattan, H. Hricak, R. Motzer, 2016, European journal of cancer.

MP39-09 GENOMIC CHARACTERIZATION OF AGGRESSIVE SPORADIC EPITHELIOID ANGIOMYOLIPOMA

P. Russo, R. Motzer, S. Tickoo, 2021 .

Renal cell carcinoma: role of MR imaging in the assessment of muscular venous branch invasion.

H. Hricak, P. Russo, O. Akin, 2013, Radiology.

Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.

K. Offit, R. Klein, P. Russo, 2016, Urologic oncology.

Multiple primary malignancies in renal cell carcinoma.

P. Russo, F. Rabbani, G. Grimaldi, 1998, The Journal of urology.

Nephrectomy during operative management of retroperitoneal sarcoma

P. Russo, William C. Huang, M. Brennan, 1997, Annals of Surgical Oncology.

Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters.

P. Russo, J. Coleman, G. Dalbagni, 2012, European urology.

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

Paul Russo, P. Russo, R. Thompson, 2008, The Journal of urology.

Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia.

Joseph R. Scarpa, Joshua S. Mincer, P. Russo, 2020, British journal of anaesthesia.

Primary genitourinary melanoma.

P. Russo, J. Katz, M. Brady, 2001, Urology.

Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.

P. Russo, W. Fair, J. Sheinfeld, 1994, The Journal of urology.

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

M. Kattan, P. Russo, B. Bochner, 2004, The Journal of urology.

Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma

L. Schwartz, J. Bacik, P. Russo, 2008, Investigational New Drugs.

Phase II trial of bortezomib for patients with advanced renal cell carcinoma.

L. Schwartz, R. Motzer, J. Bacik, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Individualized therapy of disseminated cancer using malignant melanoma as a model

A. Hauschild, K. Kähler, F. Egberts, 2006, Cancer and Metastasis Reviews.

Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma.

U. Capitanio, F. Montorsi, P. Russo, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function.

Robert G Uzzo, Stephen A Boorjian, Paul Russo, 2011, The Journal of urology.

A phase III, randomized, placebo-controlled trial of adjuvant nivolumab plus ipilimumab in patients (pts) with localized renal cell carcinoma (RCC) who are at high risk of relapse after radical or partial nephrectomy (CheckMate 914).

R. Motzer, P. Russo, A. Bex, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Partial Penectomy for Patients With Squamous Cell Carcinoma of the Penis: The Memorial Sloan-Kettering Experience

P. Russo, T. Koppie, R. Korets, 2007, Annals of Surgical Oncology.

Recovery of renal function after open and laparoscopic partial nephrectomy.

Paul Russo, Jonathan Coleman, B. Guillonneau, 2010, European urology.

Patterns of surveillance imaging after nephrectomy in the Medicare population

E. Elkin, P. Russo, W. Huang, 2016, BJU international.

Low yield of surveillance imaging after surgery for T1 kidney cancer

P. Russo, H. Vargas, J. Coleman, 2016, World Journal of Urology.

Radical nephrectomy with and without lymph node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881

P. Russo, 2009 .

Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution

P. Russo, J. Coleman, E. Zabor, 2016, World Journal of Urology.

Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy

P. Russo, 2004, Nature Clinical Practice Urology.

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.

P. Russo, R. Motzer, E. Jonasch, 2023, European urology focus.

The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-year Institutional Experience.

P. Russo, A. Hakimi, S. Tickoo, 2019, Urology.

Clinicopathologic features of renomedullary interstitial cell tumor presenting as the main solid renal mass.

P. Russo, H. Al-Ahmadie, Hong-ying Huang, 2014, Urology.

Tumor size is associated with malignant potential in renal cell carcinoma cases.

Paul Russo, Satish K. Tickoo, P. Russo, 2009, The Journal of urology.

Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy.

P. Russo, S. Solomon, R. Thornton, 2011, The Journal of urology.

Upper tract urothelial carcinoma in a patient with horseshoe kidney.

P. Russo, S. Sirintrapun, N. Almassi, 2020, Urology.

Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.

P. Russo, R. Thompson, C. Lohse, 2009, The Journal of urology.

Editorial Comment.

P. Russo, 2019, Journal of Urology.

A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

J. Kaouk, P. Russo, R. Thompson, 2015, European urology.

New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.

Paul Russo, William C Huang, P. Russo, 2013, Urology.

Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists.

P. Russo, P. Kim, B. Ehdaie, 2013, The Journal of urology.

Ureteral obstruction and stents: still a difficult problem for patients and urologists alike.

P. Russo, 2005, The Journal of urology.

The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.

R. Motzer, P. Russo, T. Choueiri, 2019, European urology oncology.

Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.

E. Wallen, F. Montorsi, P. Russo, 2014, European urology.

CKD and the risk of incident cancer.

A. Go, W. Lowrance, P. Russo, 2014, Journal of the American Society of Nephrology : JASN.

Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008.

P. Russo, M. Kaag, C. Savage, 2011, The Journal of urology.

A case of port-site recurrence and locoregional metastasis after laparoscopic partial nephrectomy

P. Russo, T. Masterson, 2008, Nature Clinical Practice Urology.

Partial nephrectomy for selected renal cortical tumours of ≥7 cm

T. Jang, P. Russo, M. O’Brien, 2010, BJU international.

Metastatic renal cell carcinoma risk according to tumor size.

P. Russo, R. Thompson, J. Coleman, 2009, The Journal of urology.

The role of surgery in the management of early-stage renal cancer.

P. Russo, 2011, Hematology/oncology clinics of North America.

Fetal lobation. An anatomo‐ultrasonographic correlation.

P. Russo, M. Lafortune, J. Lefaivre, 1990, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

CT of renal cell carcinoma: assessment of collecting system invasion.

H. Hricak, P. Russo, O. Akin, 2013, AJR. American journal of roentgenology.

Sudden unexpected deaths in infancy: what are the causes?

P. Russo, A. Côté, J. Michaud, 1999, The Journal of pediatrics.

Impact of warm versus cold ischemia on renal function following partial nephrectomy

P. Russo, J. Wolf, M. Clark, 2014, World Journal of Urology.

Trends in renal tumor surgery delivery within the United States

W. Lowrance, P. Russo, W. Huang, 2010, Cancer.

Phase II Trial of Pegylated Interferon-α2b in Patients with Advanced Renal Cell Carcinoma

L. Schwartz, P. Russo, R. Motzer, 2008 .

Pheochromocytoma arising in the setting of adrenal–renal fusion: a case report

P. Russo, V. Reuter, S. Basourakos, 2022 .

Risk score and metastasectomy independently impact prognosis of patients with recurrent renal cell carcinoma.

P. Russo, R. Motzer, S. Eggener, 2008, The Journal of urology.

Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer.

P. Russo, E. Zabor, H. Furberg, 2014, The Journal of urology.

Expression of prostate-specific membrane antigen in renal cortical tumors

P. Russo, V. Reuter, R. Motzer, 2008, Modern Pathology.

Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival.

H. Hricak, P. Russo, O. Akin, 2016, AJR. American journal of roentgenology.

Hereditary and familial kidney cancer.

P. Russo, J. Coleman, 2009, Current opinion in urology.

Preoperative nomogram predicting 12-year probability of metastatic renal cancer.

M. Kattan, P. Russo, R. Thompson, 2008, The Journal of urology.

Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.

P. Russo, N. Mitra, S. Donat, 2006, The Journal of urology.

Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience

P. Russo, B. Bochner, G. Dalbagni, 2014, International scholarly research notices.

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Paul Russo, P. Russo, B. Bochner, 2004, The Journal of urology.

Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics

W. Lowrance, P. Russo, D. Sjoberg, 2015, World Journal of Urology.

Chronic Kidney Disease Epidemiology Collaboration versus Modification of Diet in Renal Disease equations for renal function evaluation in patients undergoing partial nephrectomy.

A. Shalhav, P. Russo, J. Wolf, 2010, The Journal of urology.

The association between modifiable perioperative parameters and renal function after nephrectomy

Joshua S. Mincer, P. Russo, A. Hakimi, 2021, BJU international.

Functional preservation in patients with renal cortical tumors: The rationale for partial nephrectomy

P. Russo, 2008, Current urology reports.

Advanced‐stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection

T. Jang, P. Russo, W. Jarnagin, 2009, BJU international.

LC-MS/MS Validation for Drug of Abuse Testing Utilizing a Split Sample Oral Fluid Collection System.

P. Russo, V. Espina, Marissa Howard, 2020 .

Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.

E. Wallen, F. Montorsi, P. Russo, 2015, The Journal of urology.

1907 LEVEL OF THROMBOUS ACCORDING TO MAYO CLINIC CLASSIFICATION IS AN INDEPENDENT PREDICTOR OF PERIOPERATIVE COMPLICATIONS AND CANCER-RELATED OUTCOME: DATA OF THE IRCVT RCC VENOUS THROMBUS CONSORTIUM

E. Wallen, F. Montorsi, P. Russo, 2013 .

1760 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS. INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM

U. Capitanio, F. Montorsi, P. Russo, 2011 .

534 CANCER-SPECIFIC SURVIVAL NOMOGRAM FOR RENAL TUMORS WITH VENOUS EXTENSION:INTERNATIONAL RENAL CELL-CARCINOMA-VENOUS THROMBUS CONSORTIUM

U. Capitanio, F. Montorsi, P. Russo, 2011 .

959 THE IMPACT OF LOCAL AND DISTANT METASTASIS ON SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY WITH TUMOR THROMBECTOMY

Jennifer M Wu, U. Capitanio, F. Montorsi, 2011 .

263 IMPACT OF CARDIOPULMONARY BY-PASS IN CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA AND LEVEL III/IV THROMBUS

U. Capitanio, P. Russo, A. Briganti, 2011 .

Urologic sarcoma in adults. Memorial Sloan-Kettering Cancer Center experience based on a prospective database between 1982 and 1989.

P. Russo, 1991, The Urologic clinics of North America.

Contemporary imaging of patients with a renal mass: does size on computed tomography equal pathological size?

P. Russo, R. Thompson, M. Kaag, 2009, BJU international.

Sequential adjuvant chemotherapy after surgical resection of high‐risk urothelial carcinoma

P. Russo, M. Milowsky, D. Bajorin, 2009, Cancer.

Metastatic carcinoid tumor of the prostate.

P. Russo, V. Reuter, J. Tash, 2002, The Journal of urology.

Adult prostate sarcoma: the Memorial Sloan Kettering experience.

P. Russo, D. Sjoberg, M. Assel, 2014, Urology.

Radical Nephrectomy for Localized Renal Tumors: Optimum Oncological and Renal Functional Considerations

P. Russo, 2013 .

Surgical Approaches to Treatment of Renal Cell Carcinoma 49

P. Russo, J. Coleman, 2013 .

End Stage and Chronic Kidney Disease: Associations with Renal Cancer

P. Russo, 2012, Front. Oncol..

PARTIAL NEPHRECTOMY . PERSONAL TECHNIQUE AND CURRENT OUTCOMES

P. Russo, 2011 .

Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization

P. Russo, 2010, BJU International.

Rational approach to the treatment of a patient with a small renal cortical tumor

P. Russo, W. Huang, 2007, Nature Clinical Practice Urology.

Partial nephrectomy achieves local tumor control and prevents chronic kidney disease

P. Russo, 2006, Expert review of anticancer therapy.

Renal tumours: developing understanding leads to developments in surgical treatment

P. Russo, 2006, BJU international.

Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma.

P. Russo, R. Motzer, M. Kaag, 2011, The Journal of urology.

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis.

M. Kattan, P. Russo, O. Akin, 2021, Urologic oncology.

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.

M. Kattan, P. Russo, O. Akin, 2020, Urologic oncology.

Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.

E. Wallen, F. Montorsi, P. Russo, 2015, The Journal of urology.

LBA4 Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial

R. Motzer, P. Russo, S. Buti, 2022, Annals of Oncology.

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.

R. Motzer, P. Russo, T. Choueiri, 2021, European urology.

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

P. Russo, L. Ben-Porat, B. Bochner, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long‐Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study

P. Russo, H. Thompson, B. Lane, 2018, The Journal of urology.

Surveillance for the management of small renal masses: Utilization and outcomes in a population-based cohort.

W. Lowrance, E. Elkin, P. Russo, 2013, Journal of Clinical Oncology.

Renal cryoablation: study with care--proceed with caution.

P. Russo, 2005, Urology.

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.

C. Begg, P. Russo, V. Reuter, 1997, British journal of urology.

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

C. Begg, P. Russo, V. Reuter, 1997, Urology.

Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors.

T. Jang, P. Russo, O. Yossepowitch, 2008, Mayo Clinic proceedings.

Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.

P. Russo, B. Bochner, W. Fair, 2003, The Journal of urology.

Obesity is associated with a higher risk of clear‐cell renal cell carcinoma than with other histologies

W. Lowrance, David S. Yee, P. Russo, 2010, BJU international.

Need for Intraoperative Ultrasound and Surgical Recommendation for Partial Nephrectomy: Correlation With Tumor Imaging Features and Urologist Practice Patterns

Ivan Pedrosa, Louis Kavoussi, Alexander Brook, 2012, Ultrasound quarterly.

Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

P. Russo, C. Karlo, A. Hakimi, 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Surgery Insight: advances in techniques for open partial nephrectomy

P. Russo, W. Huang, Megan A. Kagiwada, 2007, Nature Clinical Practice Urology.

274: Phase II Trial of Intra Vesical Gemcitabine in BCG-Refractory Transitional Cell Carcinoma of the Bladder

P. Russo, M. Mazumdar, B. Bochner, 2004 .

EDITORIAL COMMENT.

P. Russo, 2021, Urology.

Platinum Priority – Review – Kidney Cancer

F. Bray, K. Bensalah, U. Capitanio, 2018 .

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

P. Russo, R. Motzer, B. Shuch, 2023, The Lancet.

Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.

P. Russo, O. Akin, R. Motzer, 2022, European Urology.

Should elective partial nephrectomy be performed for renal cell carcinoma >4 cm in size?

Paul Russo, P. Russo, 2008, Nature Clinical Practice Urology.

The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.

P. Russo, A. Hakimi, J. Coleman, 2016, Urologic oncology.

The natural history of large renal masses followed on observation.

P. Russo, A. Hakimi, J. Coleman, 2018, Urologic oncology.

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma.

S. Lowe, R. Motzer, P. Russo, 2022, Cancer discovery.

Reply to Williamson S.R. What is the malignant potential of clear cell papillary renal cell carcinoma? Urol Oncol 2016; 34: 420.

P. Russo, A. Hakimi, E. Vertosick, 2016, Urologic oncology.

Intraoperative sonography: application in renal cell carcinoma.

P. Russo, B. Gilbert, W. Fair, 1988, The Journal of urology.

Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma.

R. Motzer, P. Russo, I. Ostrovnaya, 2019, Urologic oncology.

Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline Summary.

Nofisat Ismaila, P. Russo, A. Finelli, 2017, Journal of Oncology Practice.

Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma.

H. Hricak, P. Russo, O. Akin, 2013, AJR. American journal of roentgenology.

Cost of care for malignant and benign renal masses.

M. Fine, W. Lowrance, P. Russo, 2013, The American journal of managed care.

Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.

P. Russo, O. Akin, D. Sjoberg, 2015, The Journal of urology.

The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy

P. Russo, J. Coleman, E. Zabor, 2017, Clinical genitourinary cancer.

Contemporary management of penile cancer: greater than 15 year MSKCC experience.

P. Russo, G. Dalbagni, J. Sfakianos, 2014, The Canadian journal of urology.

Contemporary understanding and management of renal cortical tumors.

P. Russo, 2008, The Urologic clinics of North America.

Patient and caregiver knowledge and utilization of partial versus radical nephrectomy: results of a national kidney foundation survey to assess educational needs of kidney cancer patients and caregivers.

P. Russo, L. Szczech, M. D. Swartz, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

PROSPECTIVE ANALYSIS OF INTRAOPERATIVE FROZEN NEEDLE BIOPSY OF SOLID RENAL MASSES IN ADULTS

P. Russo, 1999 .

RISK OF METASTATIC RENAL CELL CARCINOMA ACCORDING TO TUMOR SIZE

P. Russo, R. Thompson, J. Coleman, 2009 .

Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems

Oguz Akin, Omer Aras, Jonathan A. Coleman, 2015, World Journal of Urology.

Suicide in men with testis cancer.

P. Russo, S. Alanee, 2012, European journal of cancer care.

Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies.

P. Russo, J. Guillem, J. Shia, 2013, Clinical colorectal cancer.

Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging

P. Russo, O. Akin, S. Tickoo, 2018, The Journal of urology.

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy

P. Russo, M. Voss, J. Coleman, 2023, The Journal of urology.

Hormone-secreting metastatic interstitial cell tumor of the testis.

P. Russo, G. Bosl, W. Whitmore, 1989, The Journal of urology.

DECLININING BASELINE GFR IMPACTS SURVIVAL IN PATIENTS UNDERGOING PARTIAL OR RADICAL NEPHRECTOMY FOR RENAL CORTICAL TUMORS

T. Jang, P. Russo, R. Thompson, 2008 .

816 IMPACT OF WARM VERSUS COLD ISCHEMIA ON RENAL FUNCTION FOLLOWING NEPHRON-SPARING SURGERY

A. Shalhav, P. Russo, J. Wolf, 2010 .

Nephrometry scores and perioperative outcomes following robotic partial nephrectomy

P. Russo, J. Coleman, D. Sjoberg, 2017, International braz j urol : official journal of the Brazilian Society of Urology.

Disparities in treatment and outcome for renal cell cancer among older black and white patients

P. Russo, 2008 .

Prognostic nomogram for renal insufficiency after radical or partial nephrectomy.

M. Kattan, P. Russo, D. Sarasohn, 2005, The Journal of urology.

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.

N. Schultz, Wesley Tansey, R. Motzer, 2023, Cell metabolism.

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy.

P. Russo, I. Ostrovnaya, S. Tickoo, 2023, Urologic oncology.

Resource-efficient pooled sequencing expands translational impact in solid tumors

M. Berger, Nicole Rusk, P. Russo, 2021, bioRxiv.

Unilateral ureteral obstruction in a patient with acute leukemia

P. Russo, Dane Blumenthal, James Orr, 1990, Urologic radiology.

Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers

T. Ho, P. Russo, A. Hakimi, 2020, Scientific Reports.

Reply from Authors re: James W.F. Catto, Shahrokh F. Shariat. The Changing Face of Renal Cell Carcinoma: The Impact of Systematic Genetic Sequencing on Our Understanding of This Tumor's Biology. Eur Urol 2013;63:855–7

P. Russo, V. Reuter, J. Hsieh, 2013 .

Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma.

P. Russo, 2009, European Urology.

Comment on : Prognosis Value of

P. Russo, 2008 .

719: Renal Cell Carcinoma Recurrence Following Nephrectomy for Localized Disease: Predicting Survival from Time of Recurrence

P. Russo, R. Motzer, S. Eggener, 2006 .

A phase III, randomized, placebo-controlled trial of nivolumab or nivolumab plus ipilimumab in patients with localized renal cell carcinoma at high-risk of relapse after radical or partial nephrectomy (CheckMate 914).

R. Motzer, P. Russo, Y. Tomita, 2020 .

MP47-09 MOLECULAR CHARACTERIZATION OF SARCOMATOID CLEAR CELL RENAL CELL CARCINOMA

William Lee, P. Russo, R. Motzer, 2015 .

Editorial comment.

P. Russo, 2011, Urology.

Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.

P. Russo, F. Rabbani, 1999, Urology.

Editorial Board

Jenny Q. Shen, M. J. Foley, S. Stirling, 2013, Neurobiology of Disease.

Editorial Comment.

P. Russo, 2020, The Journal of urology.

Influence of renal biopsy results on the management of small kidney cancers in older patients: Results from a population-based cohort.

Coral L. Atoria, E. Elkin, P. Russo, 2017, Urologic oncology.

Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms.

P. Russo, E. Zabor, H. Furberg, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients

Nimrod D. Rubinstein, P. Russo, O. Akin, 2017, PloS one.

Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.

P. Russo, N. Mitra, M. Snyder, 2006, The Journal of urology.

An improved method for computerized tomography-planned transperineal 125iodine prostate implants.

J Roy, Z Fuks, J. Roy, 1991, The Journal of urology.

MP21-04 NEUTROPHIL-TO-LYMPHOCYTE RATIO IN UNCLASSIFIED RENAL CELL CARCINOMA IS ASSOCIATED WITH PROGNOSIS AND VARIES BETWEEN MOLECULAR SUBGROUPS

R. Motzer, P. Russo, J. Coleman, 2019, Journal of Urology.

Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.

F. Montorsi, P. Russo, W. Huang, 2011, European urology.

Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.

C. Bourque, N. Socci, R. Motzer, 2017, European urology focus.

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

R. Motzer, P. Russo, T. Choueiri, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hereditary and familial kidney cancer.

P. Russo, J. Coleman, 2009, Current opinion in urology.

Renal oncocytoma: a clinicopathologic study of 70 cases.

P. Russo, V. Reuter, P. Gaudin, 1997, The American journal of surgical pathology.

The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors.

P. Russo, William C. Huang, 2008, Urologic clinics of North America.

Intraoperative conversion from partial to radical nephrectomy at a single institution from 2003 to 2008.

P. Russo, M. Kaag, C. Savage, 2011, The Journal of urology.

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

P. Russo, B. Leibovich, M. Blute, 2008, The Journal of urology.

The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.

M. Bains, P. Russo, J. Wren, 2016, The Journal of urology.

Prospective trial of ifosfamide, paclitaxel, and cisplatin (ITP) in patients with advanced non-transitional cell (non-TCC) carcinomas of the urothelial tract.

P. Russo, M. Galsky, B. Bochner, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Seeking the solution to the problem of metastatic renal carcinoma

P. Russo, 2003, Cancer.

RoboMutts

Nick Barnes, Andrew Blair, Robert Sim, 2000, Robot Soccer World Cup.

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

R. Motzer, P. Russo, A. Hakimi, 2017, Urologic oncology.

Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.

P. Russo, V. Reuter, S. Tickoo, 2009, The Journal of urology.

Prognostic Factors for Survival in Patients Undergoing Surveillance After Cytoreductive Nephrectomy

P. Russo, M. Voss, J. Coleman, 2023, The Journal of urology.

Complications after radical and partial nephrectomy as a function of age.

W. Lowrance, P. Russo, A. Vickers, 2010, The Journal of urology.

Evolving strategies for renal tumor surgery: whether by open or by laparoscopic approaches, do the right operation!

P. Russo, 2005, Urologic oncology.